Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Technology » Pharmaceuticals Major
symbol | company | %chng | last | %short | avg$volume | |
---|---|---|---|---|---|---|
BMY | Bristol-Myers Squibb Co. | 2.06% | 63.70 | 1.4% | $1705.23m | |
JNJ | Johnson & Johnson | -0.01% | 140.97 | 0.7% | $887.68m | |
PFE | Pfizer Inc. | 0.67% | 38.48 | 0.9% | $748.16m | |
MRK | Merck & Co., Inc. | 0.56% | 89.48 | 0.7% | $690.58m | |
ABBV | AbbVie, Inc. | 1.12% | 87.67 | 2.3% | $630.85m | |
LLY | Eli Lilly & Co. | 0.39% | 121.25 | 1.1% | $359.02m | |
NVS | Novartis AG | -0.40% | 92.67 | 0.2% | $145.29m | |
AZN | AstraZeneca Plc | -0.31% | 48.04 | 1.2% | $139.30m | |
GSK | GlaxoSmithKline Plc | -0.93% | 45.86 | 0.2% | $134.68m | |
RETA | Reata Pharmaceuticals, Inc. | 0.63% | 200.80 | 3.5% | $133.40m | |
KRTX | Karuna Therapeutics, Inc. | 2.45% | 66.00 | 0.0% | $101.36m | |
SNY | Sanofi | 0.33% | 49.17 | 0.2% | $100.39m | |
NVO | Novo Nordisk A/S | -0.69% | 56.47 | 0.1% | $87.98m | |
ALLK | Allakos, Inc. | 1.26% | 122.79 | 0.0% | $74.09m | |
FTSV | Forty Seven, Inc. | 4.28% | 37.50 | 0.0% | $44.08m |
Company Profile
Mustang Bio, Inc. is a clinical-stage biopharmaceutical company that focuses on the development and commercialization of a broad range of proprietary chimeric antigen receptor engineered T cell (CAR T) immunotherapies and gene therapies. It develops CAR T and CRISPR/Cas9-enhanced CAR T therapies across multiple cancers, as well as lentiviral gene therapy for XSCID. The firm's products include MB-101 IL13Ra2-specific CAR, MB-102 CD123 CAR, MB-103 HER2 CAR, MB-104 CS1 CAR, MB-105 PSCA CAR, MB-106 CD20 CAR, MB-107 XSCID Gene Therapy and Oncolytic Virus (C134). The company was founded on March 13, 2015 and is headquartered in New York, NY.